Last reviewed · How we verify

NCT06318546

Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section

Completed Phase 1 Last updated 5 November 2024
What this trial tests

Phase 1 trial testing Dexmedetomidine Injection [Precedex],,, in Post Spinal Shivering in 130 participants. Completed in 31 August 2024.

Timeline
1 April 2024
Primary endpoint
31 August 2024
31 August 2024

Quick facts

Lead sponsorAin Shams University
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment130
Start date1 April 2024
Primary completion31 August 2024
Estimated completion31 August 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 35, female only, with Post Spinal Shivering. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will test the effects of intrathecal dexmedetomidine as adjuvant to intrathecal bupivacaine and it's direct effect in decreasing incidence of post spinal shivering in Parturients Undergoing Caesarean section

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06318546.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing